Nail Psoriasis Severity Index: a useful tool for evaluation of nail psoriasis
P Rich, RK Scher - Journal of the American Academy of Dermatology, 2003 - Elsevier
The Nail Psoriasis Severity Index (NAPSI) is a numeric, reproducible, objective, simple tool
for evaluation of nail psoriasis. This scale is used to evaluate the severity of nail bed …
for evaluation of nail psoriasis. This scale is used to evaluate the severity of nail bed …
Recommendations for the definition, evaluation, and treatment of nail psoriasis in adult patients with no or mild skin psoriasis: a dermatologist and nail expert group …
…, M Iorizzo, M Pasch, BM Piraccini, P Rich… - Journal of the American …, 2019 - Elsevier
Nail involvement in psoriasis is common, and the severity of it does not always parallel the
intensity of cutaneous disease. We created a consensus group, of which the aim was to …
intensity of cutaneous disease. We created a consensus group, of which the aim was to …
The epidemiology, etiology, and pathophysiology of onychomycosis
RK Scher, P Rich, D Pariser, B Elewski - , 32, 2013 - ingentaconnect.com
The prevalence of onychomycosis in the United States is estimated to be at least 12%;
prevalence increases with increasing age and is highest in individuals more than 65 years of age. …
prevalence increases with increasing age and is highest in individuals more than 65 years of age. …
Secukinumab induction and maintenance therapy in moderate‐to‐severe plaque psoriasis: a randomized, double‐blind, placebo‐controlled, phase II regimen‐finding …
P Rich, B Sigurgeirsson, D Thaci… - British Journal of …, 2013 - academic.oup.com
Background Interleukin (IL)‐17A has major proinflammatory activity in psoriatic lesional skin.
Objectives To assess the efficacy and safety of secukinumab, a fully human IgG1κ …
Objectives To assess the efficacy and safety of secukinumab, a fully human IgG1κ …
[HTML][HTML] Melanonychia
J Jefferson, P Rich - Dermatology Research and Practice, 2012 - hindawi.com
Melanonychia, or melanin-derived brown-to-black nail pigmentation, is a diagnostic challenge
for clinicians. The most serious disease of the nail unit, melanoma, primarily presents with …
for clinicians. The most serious disease of the nail unit, melanoma, primarily presents with …
[HTML][HTML] Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double …
…, H Sofen, L Kircik, KB Gordon, P Foley, P Rich… - Journal of the American …, 2023 - Elsevier
… Dr Rich has received research grants as a principal investigator on pharmaceutical trials
from AbbVie, Arcutis, Bristol Myers Squibb, Dermavant, Eli Lilly, Janssen, Novartis, Sun Pharma…
from AbbVie, Arcutis, Bristol Myers Squibb, Dermavant, Eli Lilly, Janssen, Novartis, Sun Pharma…
Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: a double-blind, randomized, vehicle-controlled study
JK Geisse, P Rich, A Pandya, K Gross, K Andres… - Journal of the American …, 2002 - Elsevier
Background: Imiquimod 5% cream may provide an effective nonsurgical treatment for
superficial basal cell carcinoma (sBCC) based on results of previous studies. Objective: The …
superficial basal cell carcinoma (sBCC) based on results of previous studies. Objective: The …
Efinaconazole 10% solution in the treatment of toenail onychomycosis: two phase III multicenter, randomized, double-blind studies
BE Elewski, P Rich, R Pollak, DM Pariser… - Journal of the American …, 2013 - Elsevier
BACKGROUND: Onychomycosis is a common nail infection, often resulting in nail plate
damage and deformity. Topical lacquer treatments have negligible efficacy. Oral treatments, …
damage and deformity. Topical lacquer treatments have negligible efficacy. Oral treatments, …
Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of …
…, GF Webster, M Jackson, M Rendon, P Rich… - Journal of the American …, 2007 - Elsevier
BACKGROUND: Doxycycline monotherapy at antimicrobial doses has been shown to be
effective for the treatment of rosacea. OBJECTIVE: To evaluate the efficacy and safety of once-…
effective for the treatment of rosacea. OBJECTIVE: To evaluate the efficacy and safety of once-…
[PDF][PDF] Efficacy and safety of a new triple-combination agent for the treatment of facial melasma
SC Taylor, H Torok, T Jones, N Lowe, P Rich… - CUTIS-NEW …, 2003 - cdn.mdedge.com
Methods Study Design—The 2 pivotal trials used similar multicenter, randomized, investigator-blind,
activecontrol, parallel-group protocols. Thirteen centers were involved in these trials…
activecontrol, parallel-group protocols. Thirteen centers were involved in these trials…